五草肾炎汤联合缬沙坦胶囊治疗脾肾气虚型慢性肾小球肾炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692.31

基金项目:


Clinical Study on Wucao Shenyan Decoction Combined with Valsartan Capsules for Chronic Glomerulonephritis of Spleen-Kidney Qi Deficiency Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察五草肾炎汤联合缬沙坦胶囊治疗慢性肾小球肾炎(CGN) 的疗效。方法:选取86 例 CGN 患者,按随机数字表法分为观察组及对照组各43 例,对照组口服缬沙坦胶囊治疗,观察组在对照组基础 上采用五草肾炎汤治疗。观察2 组临床疗效及不良反应发生情况,比较2 组治疗前后中医证候积分、肾功 能[尿氮素(BUN)、肌酐(SCr)] 水平、低氧诱导因子-1α (HIF-1α)、白细胞介素-8 (IL-8)、白细胞介 素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、尿液指标[尿微量白蛋白(mAlb)、α1-微球蛋白(α1-MG)] 值的变 化。结果:观察组临床疗效总有效率为90.70%,对照组为74.42%,2 组比较,差异有统计学意义(P< 0.05)。治疗后,2 组腰脊酸痛、疲倦乏力、面浮肢肿、纳少腹胀、少气懒言中医证候积分均较治疗前下 降(P<0.05),观察组上述5 项积分均低于对照组(P<0.05)。治疗后,2 组BUN、SCr 水平均较治疗前下 降(P<0.05),观察组BUN、SCr 水平均低于对照组(P<0.05)。治疗后,2 组血清HIF-1α 及尿mAlb、 α1-MG 水平均较治疗前下降(P<0.05),观察组上述3 项水平均低于对照组(P<0.05)。治疗后,2 组血清 IL-8、IL-6、TNF-α 水平均较治疗前下降(P<0.05),观察组上述3 项水平均低于对照组(P<0.05)。结论: 五草肾炎汤联合缬沙坦胶囊能改善CGN 患者临床症状,缓解肾小球损伤程度,减轻炎症反应,促进肾功能恢复。

    Abstract:

    Abstract: Objective: To observe the curative effect of Wucao Shenyan Decoction combined with Valsartan Capsules for chronic glomerulonephritis(CGN), and its effect on Chinese medicine syndromes, kidney function and levels of serum hypoxia inducible factor-1α(HIF-1α),urinary microalbumin(mALB) and α1- microglobulin(α1- MG). Methods: A total of 86 cases of patients with CGN were divided into the observation group and the control group according to the random number table method,with 43 cases in each group. The control group was given the oral administration of Valsartan Capsules,and the observation group was additionally treated with Wucao Shenyan Decoction based on the treatment of the control group. The clinical effects and the incidence of adverse reactions in the two groups were observed. Before and after treatment, the changes in traditional Chinese medicine(TCM) syndrome scores, levels of kidney function including urinary nitrogen(BUN) and creatinine(SCr), hypoxia inducible factor- 1α(HIF- 1α), interleukin- 8(IL- 8), interleukin- 6(IL- 6), tumor necrosis factor- α(TNF- α), and values of urine indexes including urinary microalbumin(mAlb) and α1- microglobulin(α1- MG) in the two groups were compared. Results:The total effective rate of clinical effect was 90.70% in the observation group and 74.42% in the control group, the difference being significant(P<0.05). After treatment, the scores of TCM syndromes including aching pain in lumbar vertebra,fatigue and lack of strength,puffy face and swollen limbs,poor appetite and abdominal distension, and shortage of qi and disinclination to talk in the two groups were decreased when compared with those before treatment(P<0.05), and the above five scores in the observation group were lower than those in the control group(P<0.05). After treatment,the levels of BUN and SCr in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of BUN and SCr in the observation group were lower than those in the control group(P<0.05). After treatment,the levels of serum HIF-1α,urinary mAlb and α1-MG in the two groups were decreased when compared with those before treatment(P<0.05),and the above three levels in the observation group were lower than those in the control group(P<0.05). After treatment, the levels of IL- 8, IL- 6 and TNF- α in serum in the two groups were decreased when compared with those before treatment(P<0.05),and the above three levels in the observation group were lower than those in the control group(P<0.05). Conclusion:The therapy of Wucao Shenyan Decoction combined with Valsartan Capsules can improve the clinical symptoms of CGN patients, alleviate glomerular injury, and reduce inflammatory responses, promote the recovery of kidney function.

    参考文献
    相似文献
    引证文献
引用本文

陈然,陈建晓,马小青.五草肾炎汤联合缬沙坦胶囊治疗脾肾气虚型慢性肾小球肾炎临床研究[J].新中医,2023,55(1):100-104

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-17
  • 出版日期:
文章二维码